Study Start-Up

Latest News

Image credit: ryanking999 | stock.adobe.com
Five Critical Qualities for Identifying a Partner to Globally Scale Ophthalmology Clinical Trials

March 22nd 2024

Amplifying the size and diversity of participant pools in clinical trials enhances statistical power and increases the generalizability of study findings.

Towards Data-Driven Clinical Trial Planning and Strategy

December 16th 2021

Orchestrating Different Levels of a Successful Clinical Study Start-Up
Orchestrating Different Levels of a Successful Clinical Study Start-Up

November 18th 2020

COVID-19 Puts Spotlight on Study Start-up
COVID-19 Puts Spotlight on Study Start-up

November 18th 2020

Fast Tracking Study Start-Up from Site Selection to First-Patient Enrollment
Fast Tracking Study Start-Up from Site Selection to First-Patient Enrollment

November 18th 2020

More News

Site Logo

Employing the Power of Bayesian Methods to Expedite Learning

Yannis Jemiai;Natalia Muhlemann;Rajat Mukherjee;Pantelis Vlachos;Apurva Bhingare;Yuan Ji
November 18th 2020

Bayesian methods bring flexibility and speed to clinical trial design and analysis, and with increased access to the necessary computational power, are transforming today’s clinical research.

Site Logo

One IS the Loneliest Number

Wendy Tate
July 8th 2015

Why? Because more often than not, you do not want to accrue only one participant to a clinical trial.

Screen Shot 2015-03-23 at 1.30.10 PM.png

Improving Orphan Drug Patient Recruitment

Andrew Schafer
March 23rd 2015

Despite the substantial difficulties associated with orphan drug trial recruitment, this segment of the drug development market is booming.

© 2024 MJH Life Sciences

All rights reserved.